학술논문
The multi-specific VH -based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
Document Type
Article
Author
Edwards, C.J.; Sette, A.; Cox, C.; Di Fiore, B.; Wyre, C.; Sydoruk, D.; Yadin, D.; Hayes, P.; Stelter, S.; Bartlett, P.D.; Benedetti, G.; Fiaska, S.; Birkett, N.R.; Teng, Y.; Enever, C.; Archer, B.; Osuch, I.; Lewandowska, M.; Surani, Y.M.; Legg, J.; Pierce, A.J.; Zuazo, M.; Garcia-Granda, M.J.; Arasanz, H.; Bocanegra, A.; Chocarro, L.; Fernandez, G.; Kochan, G.; Escors, D.; Vera, R.
Source
In: British Journal of Cancer . (British Journal of Cancer, 3 May 2022, 126(8):1168-1177)
Subject
Language
English
ISSN
15321827
00070920
00070920